» Articles » PMID: 16865770

E-cadherin Expression Pattern in Primary Colorectal Carcinomas and Their Metastases Reflects Disease Outcome

Overview
Specialty Gastroenterology
Date 2006 Jul 26
PMID 16865770
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To investigate the changes that occur in E-cadherin expression during the process of metastasis in colorectal cancer.

Methods: E-cadherin expression was detected by immunohistochemistry and two indices of expression were calculated which reflected the level of expression and the locations (membrane and cytoplasm). Univariate and multivariate survival analyses were used to assess the value of these two E-cadherin indices as predictors of both disease-free (DFS) and disease-specific (DSS) survival.

Results: E-cadherin membrane index (MI), but not cytoplasmic index (CI), was significantly higher in primary tumors than their metastases (P = 0.0001). Furthermore, both primary tumor MI and CI were higher among the patients who developed subsequent metastasis (P = 0.022 and P = 0.007, respectively). Interestingly, both indices were higher in liver metastase compared to other anatomic sites (MI, P = 0.034 and CI, P = 0.022). The CI of the primary tumors was a significant predictor of DFS (P = 0.042, univariate analysis), with a strong inverse correlation between CI and DFS (P = 0.006, multivariate analysis). Finally, the MI of primary tumor proved to be a significant independent predictor of DSS, with higher indices being associated with a more favorable outcome (P = 0.016).

Conclusion: Examination of E-cadherin expression and distribution in colorectal tumors can be extremely valuable in predicting disease recurrence. The observation that aberrant cytoplasmic expression of E-cadherin can predict disease recurrence is obviously of great importance for both patients and clinicians, and significantly affects decisions concerning the therapy and management of the patients.

Citing Articles

Markers of Epithelial-Mesenchymal Transition and Mucinous Histology Are Significant Predictors of Disease Severity and Tumor Characteristics in Early-Onset Colorectal Cancer.

Djikic Rom A, Dragicevic S, Jankovic R, Radojevic Skodric S, Sabljak P, Markovic V Diagnostics (Basel). 2024; 14(14).

PMID: 39061649 PMC: 11275501. DOI: 10.3390/diagnostics14141512.


E-Cadherin Expression Varies Depending on the Location within the Primary Tumor and Is Higher in Colorectal Cancer with Lymphoid Follicles.

Markowski A, Ustymowicz K, Markowska A, Romanczyk W, Guzinska-Ustymowicz K Cancers (Basel). 2023; 15(12).

PMID: 37370870 PMC: 10296849. DOI: 10.3390/cancers15123260.


Effect of E-cadherin on Prognosis of Colorectal Cancer: A Meta-Analysis Update.

Chang K, Jiang L, Sun Y, Li H Mol Diagn Ther. 2022; 26(4):397-409.

PMID: 35732878 DOI: 10.1007/s40291-022-00593-3.


Utility of immunohistochemical expression of E-cadherin in colorectal carcinoma.

Rajkumar S, Gunabooshanam B, Dennis Joseph L, DCruze L Prz Gastroenterol. 2022; 17(1):59-66.

PMID: 35371360 PMC: 8942004. DOI: 10.5114/pg.2021.107801.


Assessment of mismatch repair deficiency, CDX2, beta-catenin and E-cadherin expression in colon cancer: molecular characteristics and impact on prognosis and survival - an immunohistochemical study.

Melincovici C, Bosca A, Susman S, Cutas A, Marginean M, Ilea A Rom J Morphol Embryol. 2021; 61(3):715-727.

PMID: 33817713 PMC: 8112747. DOI: 10.47162/RJME.61.3.10.


References
1.
Sanders D, Perry I, Hardy R, Jankowski J . Aberrant P-cadherin expression is a feature of clonal expansion in the gastrointestinal tract associated with repair and neoplasia. J Pathol. 2000; 190(5):526-30. DOI: 10.1002/(SICI)1096-9896(200004)190:5<526::AID-PATH564>3.0.CO;2-9. View

2.
Bendardaf R, Elzagheid A, Lamlum H, Ristamaki R, Collan Y, Pyrhonen S . E-cadherin, CD44s and CD44v6 correlate with tumour differentiation in colorectal cancer. Oncol Rep. 2005; 13(5):831-5. DOI: 10.3892/or.13.5.831. View

3.
Ikeguchi M, Taniguchi T, Makino M, Kaibara N . Reduced E-cadherin expression and enlargement of cancer nuclei strongly correlate with hematogenic metastasis in colorectal adenocarcinoma. Scand J Gastroenterol. 2000; 35(8):839-46. DOI: 10.1080/003655200750023219. View

4.
Elzagheid A, Kuopio T, Ilmen M, Collan Y . Prognostication of invasive ductal breast cancer by quantification of E-cadherin immunostaining: the methodology and clinical relevance. Histopathology. 2002; 41(2):127-33. DOI: 10.1046/j.1365-2559.2002.01448.x. View

5.
Goodsell D . The molecular perspective: cadherin. Oncologist. 2002; 7(5):467-8. DOI: 10.1634/theoncologist.7-5-467. View